Wikidata

(Q63594652)

English

A Study of KY1005 in Patients With Moderate to Severe Atopic Dermatitis

clinical trial

In more languages

Statements

title
A Phase 2a, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multicentre Study of an Anti OX40L Monoclonal Antibody (KY1005) in Moderate to Severe Atopic Dermatitis (English)
0 references
medical condition
dermatitis
0 references
eczema
0 references
country
Germany
0 references
Poland
0 references
Spain
0 references
United Kingdom
0 references
start time
13 December 2018
0 references
end time
September 2019
0 references
number of participants
84
0 references
minimum age
18 year
0 references
maximum age
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63594652&oldid=1857323444"